Clear my filters

IAVC

iAVC provides the right information at the right time. Its mission is to innovate in the management of stroke patients for the benefit of healthcare institutions.

INVENIS BIOTHERAPIES

InVenis Biotherapies is a biotech compagny developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving…

KELINDI

KELINDI is a medical app start-up studio with the aim to add 10 years of healthy life by guiding people towards appropriate care paths at the right time with the…

LAELAPS THERAPEUTICS

Pharma/Biotech

Laelaps Therapeutics’ mission is to develop therapeutic antibodies and proteins for the treatment of rare bleeding disorders including acquired Von Willebrand syndrome and haemophilia. The start-up has a pipeline of…

LIFEBLOOM

Lifebloom develops a medical device that brings physical support to dependent people who can then stand and walk autonomously. This fall-protection device is affordable and intuitive. With Lifebloom, users walk…

NANOREVIV

NanoReviv is specializing in reformulation of existing molecules to give them a second life. Thus, by improving their PK/PD characteristics thanks to their vectorization in lipid nanocapsules. A first product,…

NOSTY

Nosty is a decentralized platform where stakeholders in drug development work together to bring new therapeutics to patients faster and more efficiently than ever. The platform enables leading researchers and…

OMINI

OMINI offers a portable device for bedside blood tests. Its extensive sensor-based technology enables a range of biomarkers to be detected accurately and affordably. OMINI is currently developing a system…

OPEN STENT SOLUTION

Open Stent Solution is a Medtech Start-up specialised in cardio-devices, which develops a transcatheter solution for mitral and tricuspid valve replacement.

PAR’IMMUNE

Par’Immune is based on 20 years of academic research and clinical work on the parasitic protein P28GST. The immunomodulatory activity of the protein has been validated in several experimental models…